| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |